Microphthalmia–dermal aplasia–sclerocornea syndrome

Microphthalmia–dermal aplasia–sclerocornea syndrome
Classification and external resources
OMIM 309801

Microphthalmia–dermal aplasia–sclerocornea syndrome (also known as "MIDAS syndrome"[1]) is a condition characterized by linear skin lesions.[1][2]

It can be associated with HCCS.[3]

See also

References

  1. ^ a b Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0. 
  2. ^ Happle, R.; Daniëls, O.; Koopman, R. J. J. (1993). "MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea): an X-linked phenotype distinct from Goltz syndrome". American Journal of Medical Genetics 47 (5): 710. doi:10.1002/ajmg.1320470525. PMID 8267001.  edit
  3. ^ Wimplinger I, Morleo M, Rosenberger G, et al. (November 2006). "Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome". Am. J. Hum. Genet. 79 (5): 878–89. doi:10.1086/508474. PMC 1698567. PMID 17033964. http://linkinghub.elsevier.com/retrieve/pii/S0002-9297(07)60831-3. 

External links